SCN8A and epilepsy: Therefore, phenytoin could be an important treatment option in patients with SCN8A-related epilepsy because it is primarily expected to block the increased sodium current through the mutated Nav1.6, but not to affect the function of other VGSC not affected by the SCN8A mutation.